Sign Out
For the treatment of the following infections caused by microorganisms sensitive to azithromycin (see Precautions and Pharmacology: Pharmacodynamics under Actions): Mild to moderate community-acquired pneumonia, in particular pneumonia caused by Mycoplasma pneumoniae, Chlamydophila psittaci (ornithosis) or Chlamydophila pneumoniae (TWAR); Acute exacerbation of chronic bronchitis (adequately diagnosed); Acute bacterial sinusitis (adequately diagnosed); Tonsillitis, pharyngitis and acute otitis media in patients with hypersensitivity to beta-lactam antibiotics or when such treatment is not suitable for other reasons; Skin and soft tissue infections such as furunculosis, pyoderma, impetigo and erysipelas in patients with hypersensitivity to beta-lactam antibiotics or when such treatment is not suitable for other reasons; Uncomplicated genital infections caused by Chlamydia trachomatis or Neisseria gonorrhoeae (non-multidrug-resistant strains).
Considerations should be given to official guidance on the appropriate use of antibacterial agents.
